How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease

被引：0
|
作者：
Fujioka, Hayato [1 ]
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 15期
关键词：
uric acid; SGLT2; inhibitor; cardiovascular disease; heart failure;
D O I：
10.2169/internalmedicine.2725-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2227 / 2227
页数：1
相关论文
共 50 条
  • [21] Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
    Nashwa Ismail Hashaad
    Sahar Saad Ganeb
    Saddam A. A. Hassan
    Shimaa Hamdeen Mohamed
    Noha Hosni Ibrahim
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [22] Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease
    Tiago Emanuel M. Costa
    Julia C. Lauar
    Mariana L. R. Innecchi
    Venceslau A. Coelho
    Rosa M. A. Moysés
    Rosilene M. Elias
    International Urology and Nephrology, 2022, 54 : 2255 - 2261
  • [23] Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
    Hashaad, Nashwa Ismail
    Ganeb, Sahar Saad
    Hassan, Saddam A. A.
    Mohamed, Shimaa Hamdeen
    Ibrahim, Noha Hosni
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [24] Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease
    Costa, Tiago Emanuel M.
    Lauar, Julia C.
    Innecchi, Mariana L. R.
    Coelho, Venceslau A.
    Moyses, Rosa M. A.
    Elias, Rosilene M.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (09) : 2255 - 2261
  • [25] Treatment of Hyperuricemia in Chronic Kidney Disease
    Ramirez-Sandoval, Juan C.
    Madero, Magdalena
    URIC ACID IN CHRONIC KIDNEY DISEASE, 2018, 192 : 135 - 146
  • [26] Hyperuricemia and the problem of chronic kidney disease
    Shcherbak, A. V.
    Kozlovskaya, L. V.
    Bobkova, I. N.
    Balkarov, I. M.
    Lebedeva, M. V.
    Stakhova, T. Yu.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (06) : 100 - 104
  • [27] Dapagliflozin treatment in patients with chronic kidney disease associated with autosomal dominant polycystic kidney disease
    Yoshimoto, Masatoshi
    Sekine, Akinari
    Suwabe, Tatsuya
    Oba, Yuki
    Mizuno, Hiroki
    Yamanouchi, Masayuki
    Ubara, Yoshifumi
    Hoshino, Junichi
    Inoue, Noriko
    Tanaka, Kiho
    Hasegawa, Eiko
    Sawa, Naoki
    Wada, Takehiko
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [28] Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    Jongs, Niels
    Mcmurray, John J.
    Correa-Rotter, Ricardo
    Stefansson, Bergur
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo L.
    DIABETES, 2021, 70
  • [29] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Patrick, Stephanie A.
    Dabal, Tracey D.
    Jackson, Christopher D.
    Halalau, Alexandra
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (09) : 2915 - 2917
  • [30] Comprehensive treatment with dapagliflozin in elderly chronic kidney disease patients: Clinical efficacy and impact on body composition
    Nomura, Kazuhiro
    Takata, Toshiyuki
    Muramae, Naokazu
    Takahashi, Hiroaki
    Abe, Kozue
    Matsuda, Tomokazu
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2025, 39 (02)
12345